BNT-165e

N/A

Report date: 2026/05/13 09:11:15

Base Information

Drug NameBNT-165e

Drug Alias NameMulti-antigen RNA-based vaccineThe multi-antigen malaria vaccineRNA-based VaccineBNT-165eBNT165e

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsMalaria

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesBiontech Se

China Registration ClassN/A

Develop Information

Active CompaniesBiontech Se

Inactive CompaniesN/A

Active IndicationsMalaria

Inactive IndicationsN/A

Other Information

ATC CodeN/A